Download Files:
Rimtuzalcap
SKU
HY-109160-10 mg
Category Reference compound
Tags Membrane Transporter/Ion Channel, Neurological Disease, Potassium Channel
$150 – $1,180
Products Details
Product Description
– Rimtuzalcap (CAD-1883) is a first-in-class selective positive allosteric modulator of small-conductance calcium-activated potassium channels (SK channels). Rimtuzalcap can be used for the research of movement disorders including essential tremor (ET) and spinocerebellar ataxia (SCA)[1].
Web ID
– HY-109160
Storage Temperature
– 4°C (Powder, protect from light)
Shipping
– Room Temperature
Applications
– Neuroscience-Neuromodulation
Molecular Formula
– C18H24F2N6O
References
– [1]Crystalline forms of potassium channel modulators. WO2020086456A1.
CAS Number
– 2167246-24-2
Molecular Weight
– 378.42
Compound Purity
– 99.41
SMILES
– CC1=NN(C2=NC(N3CCOCC3)=CC(NC4CCC(F)(F)CC4)=N2)C=C1
Clinical Information
– Phase 2
Research Area
– Neurological Disease
Solubility
– DMSO : 250 mg/mL (ultrasonic)
Target
– Potassium Channel
Pathway
– Membrane Transporter/Ion Channel
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.